SUMMARY Acute left circumflex coronary artery (LC) occlusion in conscious dogs caused marked ischemia in the myocardium supplied by the occluded artery, as judged by the radioactive microsphere technique for determining blood flow distribution. With the chest open, LC pressure distal to the occlusion fell to 21 ± 1.9% of aortic pressure.
BETA-ADRENERGIC SUPPRESSION by
propranolol administration is widely used in the longterm management of patients with angina pectoris due to ischemic coronary heart disease. In patients limited by exertional angina, exercise capacity rises and the frequency of angina falls." 2 Propranolol is known to lessen the increases in heart rate and myocardial 02 consumption that occur during exercise.3 Thus, a level of physical activity which initially surpassed the capacity of the coronary circulation to deliver 02, resulting in myocardial hypoxia, apparently can be sustained without inducing myocardial hypoxia when metabolic requirements for 02 are reduced by propranolol. In this way propranolol protects the patient against transient episodes of myocardial hypoxia and angina that occur during daily activity. The rationale of using this form of therapy assumes that such protection is desirable.
Coronary collateral vessels are associated with ischemic coronary artery disease. Although indicating underlying arterial disease, the collaterals themselves are desirable. They compensate in part for the obstructive coronary disease, restore perfusion of the myocardium toward normal, promote coronary reserve and may diminish the likelihood of myocardial infarction in the event of subsequent total occlusion of a stenosed coronary artery. Local myocardial hypoxia is believed to be an important stimulus for collateral development. The possibility of further enhancing collateral development by purposefully provoked temporary periods of myocardial hypoxia is one aspect of the rationale for advocating exercise training in patients with exertional angina pectoris.
If an increase in the frequency of transient myocardial hypoxia enhances collateral development, then an intervention that alternatively reduces the frequency of myocardial hypoxia might retard collateral development. This could be an important negative effect of long-term propranolol administration, which is masked by its other beneficial effects.
In this investigation we tested the hypothesis that chronic j3-adrenergic suppression by propranolol interferes with the development of coronary collaterals in response to gradual coronary artery occlusion. We also reexamined the reports that acutely administered propranolol causes a transmural shift in coronary blood flow distribution in dogs with normal coronary circulations.7
Methods Preliminary Operative Procedures
A left thoracotomy was performed using halothane anesthesia and aseptic technique. We encircled the proximal portion of the left circumflex coronary artery (LC) with an ameroid constrictor (2.77 or 3.0 mm internal diameter) for chronic LC occlusion experiments or pneumatic cuff occluder for acute LC occlusion experiments and closed the chest.
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by fluoroscopy in the left ventricle, thoracic aorta, and coronary sinus. We retrieved the proximal end of the cuff occluder through a skin incision on the dog's back. With the dog awake and breathing spontaneously, heart rate and aortic and left ventricular blood pressures sensed by P23 Gb Statham transducers were recorded on a Brush Mark 200 ink writer, and microsphere injections were made to determine coronary blood flow distribution.
The dogs were then anesthetized using pentobarbital (approximately 15 mg/kg), and a wide left thoracotomy was carried out to measure pressures simultaneously in the aorta and in the LC immediately distal to the pneumatic cuff or ameroid.
Protocols
The acute effect of propranolol was investigated in six dogs with normal coronary circulation which had not had previous surgery. Observations were made with the dogs sedated and awake before and 20 minutes after intravenous injection of propranolol, 1 mg/kg.
Acute LC occlusion was performed in seven dogs 7-9 days after securing a pneumatic cuff on the LC. Patency of the LC initially was verified angiographically, and LC occlusion by cuff inflation was substantiated by reproducing the same electrocardiographic changes which occurred during the initial surgery. Observations were made with the dogs sedated and awake during: 1) control conditions, 2) 2-3 minutes after temporary acute LC occlusion achieved by inflation of the pneumatic cuff, and 3) 2-3 minutes after a second acute LC occlusion carried out during atrial pacing at a heart rate of 200 beats/min. Pacing was begun 20 minutes after release of the first occlusion, 5 minutes before the second occlusion. The dog then was anesthetized. With the chest open, aortic pressure (AP) and distal LC pressure (LCP) were measured simultaneously 2-3 minutes after LC ligation. The latter procedure was unsuccessful in three dogs, and we carried out the simultaneous LCP and AP measurements in three other dogs which had not undergone the remainder of the protocol.
The effect of chronic propranolol administration on coronary collateral development was investigated in 18 dogs in which gradual LC occlusion was produced by an ameroid constrictor. Propranolol 160 mg orally every 6 hours was begun in 10 dogs (body weight 22 The spheres (3M Co) were approximately 15 A in diameter and labelled with either strontium-85, cerium-141 or niobium-95, used in random sequence. Four hundred thousand to I million microspheres were introduced via the left ventricular catheter over a 15-20-second period. At the completion of the experiment, we removed the heart and separated the free wall of the left ventricle into regions supplied by the LAD and LC, based on the distribution of visible epicardial branches. Approximately 5 g of myocardium where the distal branches of the LAD and LC met near the apex were discarded. We cut the LAD and LC regions into blocks and sliced each into inner (subendocardial) and outer (subepicardial) halves. All samples were placed in 15 mm diameter glass tubes and weighed, and their radioactive emissions were counted in a Packard 5230 automatic gamma spectrometer system, calibrated with cesium-137 as a standard before each run. Coronary blood flow data are expressed only as distribution ratios between different regions of the heart. These ratios depend simply upon the counts/min per gram (attributable to the isotope administered) for one region divided by that of the other.
Statistics
Statistical significance of differences was judged by a two-tailed t test, paired or impaired as indicated.
Results

Acute Effect of Propranolol
Initial control heart rate (74 ± 6.3 beats/min, mean ± SEM), aortic blood pressure (111 ± 4.0/78 ± 3.6 mm Hg) and left ventricular end-diastolic pressure (7 ± 1.3 mm Hg) of these conscious sedated dogs with normal coronary arteries were comparable to values previously found in dogs trained to lie quietly without medication.8 Under these baseline conditions, propranolol 1 mg/kg intravenously caused no significant change in the hemodynamic parameters measured. There was no significant change in the distribution of coronary blood flow, as determined by microsphere concentration ratios, between different regions of the heart, or between the inner (subendocardial) and outer (subepicardial) layers of the left ventricular free wall (I/O) ( 
Gradual LC Occlusion Propranolol
The last columns of tables 3-5 present data for the dogs which received propranolol 160 mg orally every 6 hours for 8 weeks after implantation of the ameroid constrictor. These observations were made 21 hours after the last propranolol dose, when /3-adrenergic inhibition had mostly dissipated. Heart rate and aortic blood pressure were not significantly different between control and propranolol dogs with gradual LC occlu- Our acute LC occlusion data provide a baseline from which interim collateral development can be measured in the gradual LC occlusion experiments. Collateral growth appears to begin within a few days of coronary ischemia2' 16 and to level off 1-2 months after ameroid constrictor implantation. '7, 18 We carried out serial coronary angiography in two preliminary dogs and found that the LC occluded between 2 and 3 weeks of ameroid implantation, which is similar to findings of Scheel et al. '7 Thus, in our chronic experiments the period available for collateral growth probably was 5-6 weeks.
The interim collateral development in the gradual LC occlusion dogs resulted in higher LCP/AP and normal LC/LAD and I/O (LC) under basal conditions, as found by others.'9 20 Moreover, the constant LC/LAD during induced tachycardia implies that the collaterals in these dogs could maintain normal blood flow to the myocardial region originally supplied by the occluded artery, even under the physiologic stress of substantial increase in coronary circulatory needs. The slight decrease in I/O (LC) during tachycardia was nearly the same as in dogs with normal coronary arteries.9 This correlates with previous results showing that cardiac contraction impedes the blood flow within the myocardium which was delivered via collaterals,2" but exerts no additional compression of the epicardial collateral vessels themselves. If collateral growth is regulated to maintain a proper balance between coronary blood flow and myocardial metabolism requirements, one might suspect that chronic reduction in metabolic requirements by propranolol might retard collateral development. Although myocardial metabolic rate was not measured in these experiments, the marked attenuation of the heart rate response to isoproterenol injection during the interval between propranolol doses implies that transient increases in heart rate or inotropy from fluctuations in sympathetic activity would also be significantly reduced throughout the several weeks available for collateral development in these dogs.
There were, however, no significant differences in the LC/LAD and I/O (LC) values between propranolol and control gradual LC occlusion dogs, either under basal resting conditions or during induced tachycardia (table 4) , and distal LC pressure was not significantly different for propranolol dogs (table 5) .
Thus, we found no evidence that chronic fl-adrenergic suppression interfered with collateral development in response to LC occlusion, or with the compensatory decrease in resistance in the distal LC microvasculature needed to maintain normal blood flow with low perfusion pressure.
The impact of collaterals to the distal LC on 284 CI RCU LATION transmural coronary blood flow within the LAD region also seemed to be unaffected by chronic 4-adrenergic blockade. The decrease in I/O (LAD) which occurred in acute LC occlusion, which is normal,9 did not occur in hearts with chronic LC occlusion, with or without propranolol administration. The lower I/O in the propranolol dogs implies relatively lower blood flow in the inner layer of the myocardium, which might be interpreted as a sign of poor perfusion. However, the lower I/O was not intensified by tachycardia and appeared to occur diffusely in the left ventricle (table 4), although reaching statistical significance in the LAD region only. The explanation for the low I/O is not clear, but it does not suggest to us impaired collateral development.
